SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (2272)11/16/2004 1:06:19 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 3044
 
thanks, Ice. (eom)



To: Icebrg who wrote (2272)11/16/2004 6:45:26 PM
From: Miljenko Zuanic  Read Replies (2) | Respond to of 3044
 
All in all, Velcade is doing (in solid tumors) much worse than I thought 12 months ago.

Also, significant and shaking mismanagement of the Company at ALL LEVELS!

Miljenko



To: Icebrg who wrote (2272)11/30/2004 1:15:31 PM
From: tuck  Respond to of 3044
 
From ASH, a free full text review of the state of the art in treating MM:

asheducationbook.org

An another for NHL:

asheducationbook.org

Both mention Velcade, among others. I.E., of interest to followers of CELG and CTIC.

Cheers, Tuck


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News